Sarepta Therapeutics

Berita

Charles Schwab Investment Management Inc. mengakuisisi 12.000 saham Sarepta Therapeutics, Inc. (NASDAQ: SRPT)

Charles Schwab Investment Management Inc. mengangkat posisinya di Sarepta Therapeutics, Inc. (NASDAQ: SRPT – – Laporan GRATIS) sebesar 2,0% selama…

Read More »
Back to top button